Cardinal Health (CAH) 91.38 $CAH
Global Radiotherapy Market Forecast Report, 2020
M2 - Thu Apr 23, 5:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tl88zw/radiotherapy) has announced the addition of the "Radiotherapy Global Market Forecast (2014-2020)" report to their offering. This report analyzes the global markets for Radiotherapy. The report provides the standard and the tailored research methodology approach. The market overview offers in depth analysis for the regional and country level analysis, for instance North America (U.S., and Canada), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2012 to 2020 for each given segments and sub segments. Market data derived from the authenticated and reliable sources subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, other activities. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Analysis 4 Porters Five Force Analysis 5 Radiotherapy Market by Product Type 5.1 Non-Ionizing Radiation 5.2 Ionizing Radiation 5.3 Particle Radiation 5.4 Electron Beams 5.5 Proton Beams 5.6 Neutron Beams 5.7 Carbon Ions 5.8 Alpha and Beta Particles 5.9 Photon Radiations 5.10 Gamma Rays 5.11 X-rays 6 Radiotherapy Market by Technology 6.1 Intensity Modulated Radiation Therapy (IMRT) 6.2 3-D Conformal Radiotherapy (3D CRT) 6.3 Proton Beam Therapy 6.4 Stereotactic Technology 6.5 Tomotherapy 6.6 Adaptive Radiation Therapy 6.7 Systemic Radiation Therapy 7 Radiotherapy Market by Application 7.1 Lung Cancer 7.2 Colorectal Cancer 7.3 Prostate Cancer 7.4 Breast Cancer 7.5 Head & Neck Cancer 7.6 Brain Cancer 7.7 Spine Cancer 7.8 Cervical Cancer 8 Geographical Segmentation 9 Vendor Landscaping 10 Company Profiles - ANSTO - Accuray, Inc. - C. R. Bard, Inc. - Cardinal Health, Inc. - Covidien, Plc - GE Healthcare - IBA Group - Nordion, Inc - Siemens Healthcare - Varian Medical Systems For more information visit http://www.researchandmarkets.com/research/tl...diotherapy
VAR: 95.50 (-0.64), CAH: 91.38 (-0.12), ARAY: 9.11 (-0.11)
Cardinal Health Rises 1.27% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Apr 22, 4:53PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $90.31 to a high of $91.62. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $90.90 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 91.38 (-0.12)
SmarTrend Watching for Potential Pullback in Shares of Cardinal Health After 1.27% Gain
Comtex SmarTrend(R) - Wed Apr 22, 4:52PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $90.31 to a high of $91.62. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $90.90 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 91.38 (-0.12)
Does Drug Firm AmerisourceBergen Have Staying Power?
at Investor's Business Daily - Wed Apr 22, 2:26PM CDT
After striking a game-changing deal two years ago, drug and health supplies distributor AmerisourceBergen is primed to add in yet more ingredients to its growth formula, ranging from expansion into animal health to an expected flurry of new business...
ABC: 115.48 (+0.28), MCK: 229.20 (+0.09), WBA: 85.98 (-0.71), CAH: 91.38 (-0.12)
Uptrend Call Working As Cardinal Health Stock Rises 16.3% (CAH)
Comtex SmarTrend(R) - Wed Apr 22, 11:40AM CDT
SmarTrend identified an Uptrend for Cardinal Health (NYSE:CAH) on October 27th, 2014 at $77.91. In approximately 6 months, Cardinal Health has returned 16.34% as of today's recent price of $90.64.
CAH: 91.38 (-0.12)
Cardinal Health
at Investor's Business Daily - Mon Apr 20, 5:43PM CDT
Cardinal Health (CAH) will pay $26.8 mil in an FTC settlement stemming from allegations it monopolized diagnostic-drug sales in 25 markets and inflated prices of low-energy radiopharmaceuticals. Shares rose 0.7% to 90.14.
CAH: 91.38 (-0.12)
Cardinal Health paying $26.8 million in FTC settlement
AP - Mon Apr 20, 1:20PM CDT
NEW YORK (AP) — Cardinal Health will pay $26.8 million as part of a settlement with the Federal Trade Commission over charges it monopolized the sale in 25 markets of diagnostic drugs known as low-energy radiopharmaceuticals.
GE: 26.80 (-0.05), CAH: 91.38 (-0.12)
Chasing High Dividend Growth Rates For Higher Total Returns
Brian Ditchek - at Seeking Alpha - Sun Apr 19, 4:08AM CDT
MDT: 77.61 (-0.89), TROW: 82.57 (+0.50), CAH: 91.38 (-0.12), NUE: 48.11 (-0.31), SYY: 37.93 (-0.02), WMT: 79.84 (+0.66), ITW: 94.63 (-0.08), ADP: 85.00 (-0.76), ADM: 48.21 (-0.06), SIAL: 139.00 (+0.03), MCD: 98.74 (+1.74), LOW: 73.16 (-0.21), BEN: 51.79 (-0.09), AFL: 64.19 (+0.02)
Dividend Contenders: 28 Increases Expected In The Next 11 Weeks
David Fish - at Seeking Alpha - Fri Apr 17, 6:19PM CDT
RBCAA: 24.47 (-0.05), CAH: 91.38 (-0.12), NOC: 161.78 (-1.05), FELE: 38.72 (-0.20), AMP: 127.75 (+0.58), JW.A: 59.46 (-0.14), CFR: 70.09 (-0.96), AIZ: 60.09 (-0.41), APU: 48.17 (-0.05), IBM: 169.78 (-0.46), HDB: 56.83 (-0.18), DE: 88.39 (-0.20), MNRO: 63.35 (+0.95), NHC: 64.53 (+0.17), TRV: 103.95 (+0.47), FDX: 169.95 (-0.15), DAKT: 11.19 (+0.10), TIF: 87.12 (+0.61), SO: 44.87 (+0.18), FDS: 159.73 (+0.05), CPK: 50.27 (+0.06), EXPD: 46.46 (-0.21), VMI: 124.44 (+1.30), RBC: 77.14 (-0.19), WRB: 49.76 (+0.25)
Why CVS Health And McKesson May Be Good Stock Picks
at Investor's Business Daily - Thu Apr 16, 4:54PM CDT
As March data pointed to a strong month for prescription drugs sold in the U.S., two stocks in the supply chain were singled out Thursday as "top ideas." In a drug supply-chain report, Evercore ISI singled out CVS Health (CVS) and drug-distribution...
ESRX: 87.34 (+0.45), MCK: 229.20 (+0.09), CAH: 91.38 (-0.12), CVS: 101.58 (+0.70), AET: 108.82 (-0.08)
NovaBay Signs Distribution Agreement with AmerisourceBergen Corporation for Avenova
Business Wire - Thu Apr 16, 6:00AM CDT
NovaBay(R) Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on the commercialization and development of its non-antibiotic anti-infective products, announces that it has signed a nationwide distribution agreement with AmerisourceBergen, one of the largest global pharmaceutical sourcing and distribution services companies.
ABC: 115.48 (+0.28), MCK: 229.20 (+0.09), CAH: 91.38 (-0.12), NBY: 0.63 (unch)
Cardinal Health Has Returned 16.4% Since SmarTrend Recommendation (CAH)
Comtex SmarTrend(R) - Wed Apr 15, 10:02AM CDT
SmarTrend identified an Uptrend for Cardinal Health (NYSE:CAH) on October 27th, 2014 at $77.91. In approximately 6 months, Cardinal Health has returned 16.38% as of today's recent price of $90.67.
CAH: 91.38 (-0.12)
2015 GenerationRx Awards Mark Continuation of Partnership to Prevent Prescription Drug Misuse
PR Newswire - Wed Apr 15, 7:30AM CDT
With more than 15 million people aged 12 or older using prescription drugs non-medically annually, prevention education is key to reversing the trend of misuse1. The Cardinal Health Foundation and the American Pharmacists Association (APhA) recently recognized pharmacists for their outstanding efforts in prescription medication misuse prevention.
CAH: 91.38 (-0.12)
Akers' Distribution Deals Expand International Footprint - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 14, 12:00PM CDT
Akers Biosciences Inc. (AKER) announced distribution agreements that will expand its international footprint.
SRDX: 26.53 (+0.03), CAH: 91.38 (-0.12), LMAT: 8.60 (+0.03), AKER: 4.65 (unch)
J&J Beats on Q1 Earnings, Cuts View on Currency Woes - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Apr 14, 9:45AM CDT
Although Johnson & Johnson's (JNJ) results surpassed expectations, the company cut its 2015 earnings outlook to reflect the strengthening dollar.
BIIB: 401.71 (-28.57), JNJ: 101.08 (+0.62), CAH: 91.38 (-0.12), AMGN: 167.91 (-1.26)
LabCorp Boosts Specialty Testing with Forensics Partnership - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 13, 3:58PM CDT
Bode Cellmark Forensics, a wholly-owned subsidiary of Laboratory Corporation of America Holdings (LH) recently tied up with the Committee on Missing Persons (CMP).
ABC: 115.48 (+0.28), CAH: 91.38 (-0.12), LH: 126.93 (+0.55), MMSI: 20.58 (+1.34)
10 Dividend Growth Stocks For April 2015
FerdiS - at Seeking Alpha - Mon Apr 13, 2:22PM CDT
HOG: 57.23 (+0.28), ADM: 48.21 (-0.06), LAZ: 55.89 (-0.32), IBM: 169.78 (-0.46), CMI: 136.50 (+0.05), CAH: 91.38 (-0.12), QCOM: 68.24 (-0.10), MGA: 52.36 (-0.70), CNQ: 33.62 (-0.01), CNP: 21.05 (+0.08), GPS: 40.86 (-0.36), MSFT: 47.87 (+4.53), VZ: 50.03 (-0.02), CMP: 88.45 (-0.73)
Retail ETFs Soar to New Highs Despite Slump in Retail Sales
at The Street - Mon Apr 13, 6:10AM CDT
Should investors be worried about a growing disconnect between record-high retail ETF prices and slumping retail sales? Retail sales data, out Tuesday, has fallen for the past 3 months.
AMZN: 445.10 (+55.11), HD: 113.70 (-0.26), KR: 71.70 (+0.77), MCK: 229.20 (+0.09), CAH: 91.38 (-0.12), DPLO: 36.71 (+0.46), WMT: 79.84 (+0.66), RTH: 77.90 (+1.12), FIVE: 36.04 (+0.10), XRT: 100.98 (+0.18), KMX: 69.97 (-0.75), WBA: 85.98 (-0.71), CONN: 30.85 (+0.15), JCP: 8.41 (-0.07), COST: 148.12 (+0.82), CVS: 101.58 (+0.70)
Health Care Providers and Services Stocks Technical Snapshot - Express Scripts Holding, Aetna, AmerisourceBergen, Cardinal Health, and McKesson Corp.
PR Newswire - Thu Apr 09, 8:30AM CDT
Editor Note: For more information about this release, please scroll to bottom.
ABC: 115.48 (+0.28), ESRX: 87.34 (+0.45), MCK: 229.20 (+0.09), CAH: 91.38 (-0.12), AET: 108.82 (-0.08)
Cardinal Health to Release Third-Quarter Results for Fiscal Year 2015 on April 30
PR Newswire - Thu Apr 09, 7:30AM CDT
Cardinal Health plans to release third-quarter financial results for its fiscal year 2015 on April 30 prior to the opening of trading on the New York Stock Exchange.
CAH: 91.38 (-0.12)
Global Radiotherapy Market Forecast Report, 2020
M2 - Thu Apr 23, 5:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tl88zw/radiotherapy) has announced the addition of the "Radiotherapy Global Market Forecast (2014-2020)" report to their offering. This report analyzes the global markets for Radiotherapy. The report provides the standard and the tailored research methodology approach. The market overview offers in depth analysis for the regional and country level analysis, for instance North America (U.S., and Canada), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2012 to 2020 for each given segments and sub segments. Market data derived from the authenticated and reliable sources subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, other activities. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Analysis 4 Porters Five Force Analysis 5 Radiotherapy Market by Product Type 5.1 Non-Ionizing Radiation 5.2 Ionizing Radiation 5.3 Particle Radiation 5.4 Electron Beams 5.5 Proton Beams 5.6 Neutron Beams 5.7 Carbon Ions 5.8 Alpha and Beta Particles 5.9 Photon Radiations 5.10 Gamma Rays 5.11 X-rays 6 Radiotherapy Market by Technology 6.1 Intensity Modulated Radiation Therapy (IMRT) 6.2 3-D Conformal Radiotherapy (3D CRT) 6.3 Proton Beam Therapy 6.4 Stereotactic Technology 6.5 Tomotherapy 6.6 Adaptive Radiation Therapy 6.7 Systemic Radiation Therapy 7 Radiotherapy Market by Application 7.1 Lung Cancer 7.2 Colorectal Cancer 7.3 Prostate Cancer 7.4 Breast Cancer 7.5 Head & Neck Cancer 7.6 Brain Cancer 7.7 Spine Cancer 7.8 Cervical Cancer 8 Geographical Segmentation 9 Vendor Landscaping 10 Company Profiles - ANSTO - Accuray, Inc. - C. R. Bard, Inc. - Cardinal Health, Inc. - Covidien, Plc - GE Healthcare - IBA Group - Nordion, Inc - Siemens Healthcare - Varian Medical Systems For more information visit http://www.researchandmarkets.com/research/tl...diotherapy
VAR: 95.50 (-0.64), CAH: 91.38 (-0.12), ARAY: 9.11 (-0.11)
Cardinal Health Rises 1.27% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Apr 22, 4:53PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $90.31 to a high of $91.62. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $90.90 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 91.38 (-0.12)
SmarTrend Watching for Potential Pullback in Shares of Cardinal Health After 1.27% Gain
Comtex SmarTrend(R) - Wed Apr 22, 4:52PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $90.31 to a high of $91.62. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $90.90 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 91.38 (-0.12)
Does Drug Firm AmerisourceBergen Have Staying Power?
at Investor's Business Daily - Wed Apr 22, 2:26PM CDT
After striking a game-changing deal two years ago, drug and health supplies distributor AmerisourceBergen is primed to add in yet more ingredients to its growth formula, ranging from expansion into animal health to an expected flurry of new business...
ABC: 115.48 (+0.28), MCK: 229.20 (+0.09), WBA: 85.98 (-0.71), CAH: 91.38 (-0.12)
Uptrend Call Working As Cardinal Health Stock Rises 16.3% (CAH)
Comtex SmarTrend(R) - Wed Apr 22, 11:40AM CDT
SmarTrend identified an Uptrend for Cardinal Health (NYSE:CAH) on October 27th, 2014 at $77.91. In approximately 6 months, Cardinal Health has returned 16.34% as of today's recent price of $90.64.
CAH: 91.38 (-0.12)
Cardinal Health
at Investor's Business Daily - Mon Apr 20, 5:43PM CDT
Cardinal Health (CAH) will pay $26.8 mil in an FTC settlement stemming from allegations it monopolized diagnostic-drug sales in 25 markets and inflated prices of low-energy radiopharmaceuticals. Shares rose 0.7% to 90.14.
CAH: 91.38 (-0.12)
Cardinal Health paying $26.8 million in FTC settlement
AP - Mon Apr 20, 1:20PM CDT
NEW YORK (AP) — Cardinal Health will pay $26.8 million as part of a settlement with the Federal Trade Commission over charges it monopolized the sale in 25 markets of diagnostic drugs known as low-energy radiopharmaceuticals.
GE: 26.80 (-0.05), CAH: 91.38 (-0.12)
Chasing High Dividend Growth Rates For Higher Total Returns
Brian Ditchek - at Seeking Alpha - Sun Apr 19, 4:08AM CDT
MDT: 77.61 (-0.89), TROW: 82.57 (+0.50), CAH: 91.38 (-0.12), NUE: 48.11 (-0.31), SYY: 37.93 (-0.02), WMT: 79.84 (+0.66), ITW: 94.63 (-0.08), ADP: 85.00 (-0.76), ADM: 48.21 (-0.06), SIAL: 139.00 (+0.03), MCD: 98.74 (+1.74), LOW: 73.16 (-0.21), BEN: 51.79 (-0.09), AFL: 64.19 (+0.02)
Dividend Contenders: 28 Increases Expected In The Next 11 Weeks
David Fish - at Seeking Alpha - Fri Apr 17, 6:19PM CDT
RBCAA: 24.47 (-0.05), CAH: 91.38 (-0.12), NOC: 161.78 (-1.05), FELE: 38.72 (-0.20), AMP: 127.75 (+0.58), JW.A: 59.46 (-0.14), CFR: 70.09 (-0.96), AIZ: 60.09 (-0.41), APU: 48.17 (-0.05), IBM: 169.78 (-0.46), HDB: 56.83 (-0.18), DE: 88.39 (-0.20), MNRO: 63.35 (+0.95), NHC: 64.53 (+0.17), TRV: 103.95 (+0.47), FDX: 169.95 (-0.15), DAKT: 11.19 (+0.10), TIF: 87.12 (+0.61), SO: 44.87 (+0.18), FDS: 159.73 (+0.05), CPK: 50.27 (+0.06), EXPD: 46.46 (-0.21), VMI: 124.44 (+1.30), RBC: 77.14 (-0.19), WRB: 49.76 (+0.25)
Why CVS Health And McKesson May Be Good Stock Picks
at Investor's Business Daily - Thu Apr 16, 4:54PM CDT
As March data pointed to a strong month for prescription drugs sold in the U.S., two stocks in the supply chain were singled out Thursday as "top ideas." In a drug supply-chain report, Evercore ISI singled out CVS Health (CVS) and drug-distribution...
ESRX: 87.34 (+0.45), MCK: 229.20 (+0.09), CAH: 91.38 (-0.12), CVS: 101.58 (+0.70), AET: 108.82 (-0.08)
NovaBay Signs Distribution Agreement with AmerisourceBergen Corporation for Avenova
Business Wire - Thu Apr 16, 6:00AM CDT
NovaBay(R) Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on the commercialization and development of its non-antibiotic anti-infective products, announces that it has signed a nationwide distribution agreement with AmerisourceBergen, one of the largest global pharmaceutical sourcing and distribution services companies.
ABC: 115.48 (+0.28), MCK: 229.20 (+0.09), CAH: 91.38 (-0.12), NBY: 0.63 (unch)
Cardinal Health Has Returned 16.4% Since SmarTrend Recommendation (CAH)
Comtex SmarTrend(R) - Wed Apr 15, 10:02AM CDT
SmarTrend identified an Uptrend for Cardinal Health (NYSE:CAH) on October 27th, 2014 at $77.91. In approximately 6 months, Cardinal Health has returned 16.38% as of today's recent price of $90.67.
CAH: 91.38 (-0.12)
2015 GenerationRx Awards Mark Continuation of Partnership to Prevent Prescription Drug Misuse
PR Newswire - Wed Apr 15, 7:30AM CDT
With more than 15 million people aged 12 or older using prescription drugs non-medically annually, prevention education is key to reversing the trend of misuse1. The Cardinal Health Foundation and the American Pharmacists Association (APhA) recently recognized pharmacists for their outstanding efforts in prescription medication misuse prevention.
CAH: 91.38 (-0.12)
Akers' Distribution Deals Expand International Footprint - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 14, 12:00PM CDT
Akers Biosciences Inc. (AKER) announced distribution agreements that will expand its international footprint.
SRDX: 26.53 (+0.03), CAH: 91.38 (-0.12), LMAT: 8.60 (+0.03), AKER: 4.65 (unch)
J&J Beats on Q1 Earnings, Cuts View on Currency Woes - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Apr 14, 9:45AM CDT
Although Johnson & Johnson's (JNJ) results surpassed expectations, the company cut its 2015 earnings outlook to reflect the strengthening dollar.
BIIB: 401.71 (-28.57), JNJ: 101.08 (+0.62), CAH: 91.38 (-0.12), AMGN: 167.91 (-1.26)
LabCorp Boosts Specialty Testing with Forensics Partnership - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 13, 3:58PM CDT
Bode Cellmark Forensics, a wholly-owned subsidiary of Laboratory Corporation of America Holdings (LH) recently tied up with the Committee on Missing Persons (CMP).
ABC: 115.48 (+0.28), CAH: 91.38 (-0.12), LH: 126.93 (+0.55), MMSI: 20.58 (+1.34)
10 Dividend Growth Stocks For April 2015
FerdiS - at Seeking Alpha - Mon Apr 13, 2:22PM CDT
HOG: 57.23 (+0.28), ADM: 48.21 (-0.06), LAZ: 55.89 (-0.32), IBM: 169.78 (-0.46), CMI: 136.50 (+0.05), CAH: 91.38 (-0.12), QCOM: 68.24 (-0.10), MGA: 52.36 (-0.70), CNQ: 33.62 (-0.01), CNP: 21.05 (+0.08), GPS: 40.86 (-0.36), MSFT: 47.87 (+4.53), VZ: 50.03 (-0.02), CMP: 88.45 (-0.73)
Retail ETFs Soar to New Highs Despite Slump in Retail Sales
at The Street - Mon Apr 13, 6:10AM CDT
Should investors be worried about a growing disconnect between record-high retail ETF prices and slumping retail sales? Retail sales data, out Tuesday, has fallen for the past 3 months.
AMZN: 445.10 (+55.11), HD: 113.70 (-0.26), KR: 71.70 (+0.77), MCK: 229.20 (+0.09), CAH: 91.38 (-0.12), DPLO: 36.71 (+0.46), WMT: 79.84 (+0.66), RTH: 77.90 (+1.12), FIVE: 36.04 (+0.10), XRT: 100.98 (+0.18), KMX: 69.97 (-0.75), WBA: 85.98 (-0.71), CONN: 30.85 (+0.15), JCP: 8.41 (-0.07), COST: 148.12 (+0.82), CVS: 101.58 (+0.70)
Health Care Providers and Services Stocks Technical Snapshot - Express Scripts Holding, Aetna, AmerisourceBergen, Cardinal Health, and McKesson Corp.
PR Newswire - Thu Apr 09, 8:30AM CDT
Editor Note: For more information about this release, please scroll to bottom.
ABC: 115.48 (+0.28), ESRX: 87.34 (+0.45), MCK: 229.20 (+0.09), CAH: 91.38 (-0.12), AET: 108.82 (-0.08)
Cardinal Health to Release Third-Quarter Results for Fiscal Year 2015 on April 30
PR Newswire - Thu Apr 09, 7:30AM CDT
Cardinal Health plans to release third-quarter financial results for its fiscal year 2015 on April 30 prior to the opening of trading on the New York Stock Exchange.
CAH: 91.38 (-0.12)
